Company Profiles

driven by the PitchBook Platform

BioRegen

BioRegen
2006 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$7M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of biomedical materials, regenerative medicines and new drug delivery systems. The company develops hyaluronic acid ("HA") based products with extracellular matrix materials such as hyaluronan, glycosaminoglycans and collagen for ENT, orthopedics and general surgeries.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Building B, Kangsite Industrial Park
  • 117 Xuezhuan Road, Xinbei District
  • Changzhou, Jiangsu 213125
  • China

+86 0519 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioRegen’s full profile, request a free trial.

BioRegen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 20-Apr-2011 $7M 00.00 Completed Startup
2. Early Stage VC 01-Jan-2010 00.000 Completed Startup
1. Early Stage VC 01-Nov-2008 $2.93M $2.93M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BioRegen Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ascend Capital Partners Venture Capital Minority 000 0000 000000 0
Cenova Capital Venture Capital Minority 000 0000 000000 0
Eight Roads Ventures Venture Capital Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
Jiuzhou Investment Group Minority 000 0000 000000 0

BioRegen Executive Team (1)

Name Title Board
Seat
Contact
Info
Shu Xiaozheng Founder & Chief Executive Officer